The DEA wants to place DOI and DOC, which are currently unscheduled, in Schedule I of the Controlled Substances Act – the most restricted category, for drugs deemed to have “High abuse potential with no accepted medical use.” The agency revived these attempts in December 2023. …the DEA’s filing includes a particularly lengthy section dedicated to discrediting…
“There isn’t really a psychedelic ‘underground’ anymore, said Jules Evans. “Everything is overground, not in the sense of legal, but in the sense of visible”. Consumer demand for psychedelic experiences remains, and players in the illegal market who were once discreet are becoming bolder. Chase, who started Psilouette in 2022 after leaving his corporate job…
Securities Exchange Commision (SEC) filings reveal that… atai Life Sciences disposed of around 2.7 million Compass Pathways shares for gross proceeds of just over $16 million. That represents around a third of atai’s stake in Compass. Meanwhile, Colorado is reaching its second year of decriminalizing [and legalizing] mushrooms and DMT for personal use and growth… “This 70-year effort to criminalize…
The solution to sustainability is not as simple as passing costs onto the customer… Oregon’s service centers are where people go to have a therapeutic psilocybin experiece or a guided trip, if you will. (In Colorado, these facilities are called “healing centers.”) But in Oregon, owners say the cost of doing business is so expensive…
The U.S. Department of Justice announced that the chief executive officer of psilocybin company Minerco Inc. (OTC: MINE), Julius Jenge was arrested… The former CEO was fleeing a Securities and Exchange Commission (SEC) investigation into the stock fraud allegations around the penny stock company Minerco… In 2021, the company began touting its psilocybin business and Minerco…
“I’m not going to go smoke pot and hang out on my couch for the next 20 years,” he said in an interview, criticizing the agency for failing to grasp the drug’s potential to relieve suffering. Still, it has been a brutally rough stretch for Doblin and MAPS, which over decades have shepherded an illegal…
Narrowly tailoring deflection offerings to just possession charges – not the low-level public disorder crimes that often accompany drug use – means counties “are going to miss 98% of what’s really bugging everyone,’ said Lisa Daugaard, a Seattle attorney and key architect of the LEAD model… “LEAD is intended to be a public safety, public…
The donation shows that Dr. Bronner’s is doubling down on the Oregon experiment with psilocybin despite its troubles, as outlined in Willamette Week’s cover story… service centers are struggling to make it, costs are high, and surprising backers are showing up. Bendable Therapy… the nonprofit pairs clients with licensed guides at partner facilities for psilocybin treatment.…
Lykos and its founder, Rick Doblin, have for years tried to persuade regulators and the pharmaceutical industry at large that psychedelic drugs should be used in the treatment of certain mental health conditions. “After 38 plus years of work, I’m profoundly saddened by the FDA decision around this critically needed therapy, but am heartened that…
[Friday, August 9, 2024] “…it is time for Commissioner [Robert] Califf to exercise direct oversight and order the Agency [FDA] to reassess its biased attacks on kratom and psychedelics,” Mac Haddow, senior fellow of public policy for American Kratom Association… August 12, 2024; The Food and Drug Administration (FDA) has withdrawn a request for White…
Recent Comments